ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2026
Carnosine-Related Metabolism in Rat Cardiomyocytes and Human Heart Tissue.
Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
The therapeutic potential of carnosine in healthy and diseased heart models is promising; however, the understanding of carnosine and β-alanine metabolism in cardiac tissue is lacking. Exploring how these compounds are metabolized in cardiac tissue is critical to determine their viability for in vivo supplementation studies. Two independent studies were conducted. Study 1 investigated the uptake of exogenous carnosine and β-alanine in cardiomyocytes and the influence of this on the expression of carnosine- and β-alanine-related enzyme and transporter genes. Study 2 investigated whether human cardiac tissue expresses carnosine and β-alanine metabolism proteins and the endogenous concentrations of carnosine and β-alanine. In Study 1, differentiated H9c2 cells were treated with 0.1-10.0 mM of carnosine or β-alanine for 4, 24 and 72 h. Gene expression was measured at 4 h using real-time quantitative polymerase chain reaction, and amino acid and histidine-containing dipeptides (HCD) concentrations were analyzed at all-time points using an amino acid analyzer. In Study 2, post-mortem human heart ventricle samples (n = 16) were analyzed for carnosine and β-alanine using HPLC-ESI
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.